Sridhar Kosaraju, Director at 10x Genomics, Inc. (TXG), sold 1,500 shares at $193.98 ($290K) on 2021-04-23, disclosed to the SEC on 2021-04-27.
Open-market sale of $290k TXG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $190.05 | 100 | $19K | 6.6% |
| 2 | $191.71 | 300 | $58K | 19.9% |
| 3 | $193.11 | 400 | $77K | 26.7% |
| 4 | $193.98 | 600 | $116K | 40.2% |
| 5 | $194.74 | 100 | $19K | 6.7% |
| Total | $193.08 avg | 1,500 |
| $290K |
| 100% |
| Filing → |
| TXG | SELL | 2021-10-27 | $349K | — | Filing → |
| TXG | SELL | 2021-09-24 | $239K | — | Filing → |
| TXG | SELL | 2021-08-25 | $243K | — | Filing → |